HEADER LYASE 01-APR-08 3CPR TITLE THE CRYSTAL STRUCTURE OF CORYNEBACTERIUM GLUTAMICUM TITLE 2 DIHYDRODIPICOLINATE SYNTHASE TO 2.2 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDRODIPICOLINATE SYNTHETASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 4.2.1.52; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CORYNEBACTERIUM GLUTAMICUM; SOURCE 3 ORGANISM_COMMON: BREVIBACTERIUM FLAVUM; SOURCE 4 ORGANISM_TAXID: 1718; SOURCE 5 GENE: DAPA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET23B KEYWDS (BETA/ALPHA)8-BARREL FOLD WITH A C-TERMINAL ALPHA-HELICAL SEGMENT, KEYWDS 2 AMINO-ACID BIOSYNTHESIS, CYTOPLASM, DIAMINOPIMELATE BIOSYNTHESIS, KEYWDS 3 LYASE, LYSINE BIOSYNTHESIS, SCHIFF BASE EXPDTA X-RAY DIFFRACTION AUTHOR T.J.RYDEL,E.J.STURMAN,E.A.RICE REVDAT 7 29-NOV-23 3CPR 1 REMARK REVDAT 6 30-AUG-23 3CPR 1 SEQADV LINK REVDAT 5 30-MAY-18 3CPR 1 SEQRES HET HETNAM FORMUL REVDAT 5 2 1 SHEET LINK ATOM REVDAT 4 25-OCT-17 3CPR 1 REMARK REVDAT 3 24-FEB-09 3CPR 1 VERSN REVDAT 2 25-NOV-08 3CPR 1 JRNL REVDAT 1 18-NOV-08 3CPR 0 JRNL AUTH E.A.RICE,G.A.BANNON,K.C.GLENN,S.S.JEONG,E.J.STURMAN, JRNL AUTH 2 T.J.RYDEL JRNL TITL CHARACTERIZATION AND CRYSTAL STRUCTURE OF LYSINE INSENSITIVE JRNL TITL 2 CORYNEBACTERIUM GLUTAMICUM DIHYDRODIPICOLINATE SYNTHASE JRNL TITL 3 (CDHDPS) PROTEIN. JRNL REF ARCH.BIOCHEM.BIOPHYS. V. 480 111 2008 JRNL REFN ISSN 0003-9861 JRNL PMID 18930704 JRNL DOI 10.1016/J.ABB.2008.09.018 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 26969 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : 10% OF DATA REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.400 REMARK 3 FREE R VALUE TEST SET COUNT : 2680 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 27767 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE : 0.2599 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 418 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4418 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 388 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.516 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP_MCL7.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE ACTIVE SITE LYSINE RESIDUES (176A, REMARK 3 176B) FORM A SCHIFF BASE COMPLEX WITH PYRUVATE. PROLINE RESIDUES REMARK 3 282A, 282B ARE CIS-PROLINES. REMARK 4 REMARK 4 3CPR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000047065. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28771 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.170 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.16700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1DHP WAS USED TO GET AN INITIAL MR REMARK 200 STRUCTURE SOLUTION. A BETTER MR STARTING SOLUTION RESULTED LATER REMARK 200 WHEN PDB ENTRY 1XXX WAS MADE AVAILABLE FOR USE. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 9.1 MG/ML IN 20 MM TRIS-HCL, REMARK 280 PH 8.0, 0.1M KCL, 10 MM PYRUVATE. PRECIPITANT: 24%(W/V) PEG6000, REMARK 280 50 MM NAH2PO4. 10 UL DROPLETS (5UL PROTEIN + 5 UL PRECIPITANT) REMARK 280 SUSPENDED OVER 1ML OF PRECIPITANT SOLUTION, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 67.65000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.40500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 67.65000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.40500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -76.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 72.72252 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 76.21018 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 19 -53.42 -128.29 REMARK 500 ALA A 57 34.42 70.33 REMARK 500 ARG A 85 17.51 -147.54 REMARK 500 TYR A 122 -51.64 67.07 REMARK 500 ILE A 150 74.76 -156.54 REMARK 500 ALA A 223 54.52 -141.23 REMARK 500 THR B 19 -52.95 -127.31 REMARK 500 ALA B 57 35.21 70.88 REMARK 500 ARG B 85 17.54 -147.30 REMARK 500 TYR B 122 -52.35 67.05 REMARK 500 ILE B 150 74.42 -156.34 REMARK 500 ALA B 223 56.57 -142.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT RESIDUE 269 IS LEU ACCORDING TO THE DENSITY MAPS. DBREF 3CPR A 5 304 UNP Q546B6 Q546B6_CORGL 2 301 DBREF 3CPR B 5 304 UNP Q546B6 Q546B6_CORGL 2 301 SEQADV 3CPR MET A 1 UNP Q546B6 EXPRESSION TAG SEQADV 3CPR ALA A 2 UNP Q546B6 EXPRESSION TAG SEQADV 3CPR ILE A 3 UNP Q546B6 EXPRESSION TAG SEQADV 3CPR THR A 4 UNP Q546B6 EXPRESSION TAG SEQADV 3CPR LEU A 269 UNP Q546B6 SER 266 SEE REMARK 999 SEQADV 3CPR MET B 1 UNP Q546B6 EXPRESSION TAG SEQADV 3CPR ALA B 2 UNP Q546B6 EXPRESSION TAG SEQADV 3CPR ILE B 3 UNP Q546B6 EXPRESSION TAG SEQADV 3CPR THR B 4 UNP Q546B6 EXPRESSION TAG SEQADV 3CPR LEU B 269 UNP Q546B6 SER 266 SEE REMARK 999 SEQRES 1 A 304 MET ALA ILE THR SER THR GLY LEU THR ALA LYS THR GLY SEQRES 2 A 304 VAL GLU HIS PHE GLY THR VAL GLY VAL ALA MET VAL THR SEQRES 3 A 304 PRO PHE THR GLU SER GLY ASP ILE ASP ILE ALA ALA GLY SEQRES 4 A 304 ARG GLU VAL ALA ALA TYR LEU VAL ASP LYS GLY LEU ASP SEQRES 5 A 304 SER LEU VAL LEU ALA GLY THR THR GLY GLU SER PRO THR SEQRES 6 A 304 THR THR ALA ALA GLU LYS LEU GLU LEU LEU LYS ALA VAL SEQRES 7 A 304 ARG GLU GLU VAL GLY ASP ARG ALA LYS LEU ILE ALA GLY SEQRES 8 A 304 VAL GLY THR ASN ASN THR ARG THR SER VAL GLU LEU ALA SEQRES 9 A 304 GLU ALA ALA ALA SER ALA GLY ALA ASP GLY LEU LEU VAL SEQRES 10 A 304 VAL THR PRO TYR TYR SER LYS PRO SER GLN GLU GLY LEU SEQRES 11 A 304 LEU ALA HIS PHE GLY ALA ILE ALA ALA ALA THR GLU VAL SEQRES 12 A 304 PRO ILE CYS LEU TYR ASP ILE PRO GLY ARG SER GLY ILE SEQRES 13 A 304 PRO ILE GLU SER ASP THR MET ARG ARG LEU SER GLU LEU SEQRES 14 A 304 PRO THR ILE LEU ALA VAL KPI ASP ALA LYS GLY ASP LEU SEQRES 15 A 304 VAL ALA ALA THR SER LEU ILE LYS GLU THR GLY LEU ALA SEQRES 16 A 304 TRP TYR SER GLY ASP ASP PRO LEU ASN LEU VAL TRP LEU SEQRES 17 A 304 ALA LEU GLY GLY SER GLY PHE ILE SER VAL ILE GLY HIS SEQRES 18 A 304 ALA ALA PRO THR ALA LEU ARG GLU LEU TYR THR SER PHE SEQRES 19 A 304 GLU GLU GLY ASP LEU VAL ARG ALA ARG GLU ILE ASN ALA SEQRES 20 A 304 LYS LEU SER PRO LEU VAL ALA ALA GLN GLY ARG LEU GLY SEQRES 21 A 304 GLY VAL SER LEU ALA LYS ALA ALA LEU ARG LEU GLN GLY SEQRES 22 A 304 ILE ASN VAL GLY ASP PRO ARG LEU PRO ILE MET ALA PRO SEQRES 23 A 304 ASN GLU GLN GLU LEU GLU ALA LEU ARG GLU ASP MET LYS SEQRES 24 A 304 LYS ALA GLY VAL LEU SEQRES 1 B 304 MET ALA ILE THR SER THR GLY LEU THR ALA LYS THR GLY SEQRES 2 B 304 VAL GLU HIS PHE GLY THR VAL GLY VAL ALA MET VAL THR SEQRES 3 B 304 PRO PHE THR GLU SER GLY ASP ILE ASP ILE ALA ALA GLY SEQRES 4 B 304 ARG GLU VAL ALA ALA TYR LEU VAL ASP LYS GLY LEU ASP SEQRES 5 B 304 SER LEU VAL LEU ALA GLY THR THR GLY GLU SER PRO THR SEQRES 6 B 304 THR THR ALA ALA GLU LYS LEU GLU LEU LEU LYS ALA VAL SEQRES 7 B 304 ARG GLU GLU VAL GLY ASP ARG ALA LYS LEU ILE ALA GLY SEQRES 8 B 304 VAL GLY THR ASN ASN THR ARG THR SER VAL GLU LEU ALA SEQRES 9 B 304 GLU ALA ALA ALA SER ALA GLY ALA ASP GLY LEU LEU VAL SEQRES 10 B 304 VAL THR PRO TYR TYR SER LYS PRO SER GLN GLU GLY LEU SEQRES 11 B 304 LEU ALA HIS PHE GLY ALA ILE ALA ALA ALA THR GLU VAL SEQRES 12 B 304 PRO ILE CYS LEU TYR ASP ILE PRO GLY ARG SER GLY ILE SEQRES 13 B 304 PRO ILE GLU SER ASP THR MET ARG ARG LEU SER GLU LEU SEQRES 14 B 304 PRO THR ILE LEU ALA VAL KPI ASP ALA LYS GLY ASP LEU SEQRES 15 B 304 VAL ALA ALA THR SER LEU ILE LYS GLU THR GLY LEU ALA SEQRES 16 B 304 TRP TYR SER GLY ASP ASP PRO LEU ASN LEU VAL TRP LEU SEQRES 17 B 304 ALA LEU GLY GLY SER GLY PHE ILE SER VAL ILE GLY HIS SEQRES 18 B 304 ALA ALA PRO THR ALA LEU ARG GLU LEU TYR THR SER PHE SEQRES 19 B 304 GLU GLU GLY ASP LEU VAL ARG ALA ARG GLU ILE ASN ALA SEQRES 20 B 304 LYS LEU SER PRO LEU VAL ALA ALA GLN GLY ARG LEU GLY SEQRES 21 B 304 GLY VAL SER LEU ALA LYS ALA ALA LEU ARG LEU GLN GLY SEQRES 22 B 304 ILE ASN VAL GLY ASP PRO ARG LEU PRO ILE MET ALA PRO SEQRES 23 B 304 ASN GLU GLN GLU LEU GLU ALA LEU ARG GLU ASP MET LYS SEQRES 24 B 304 LYS ALA GLY VAL LEU MODRES 3CPR KPI A 176 LYS NZ-(1-CARBOXYETHYL)-LYSINE MODRES 3CPR KPI B 176 LYS NZ-(1-CARBOXYETHYL)-LYSINE HET KPI A 176 14 HET KPI B 176 14 HETNAM KPI (2S)-2-AMINO-6-[(1-HYDROXY-1-OXO-PROPAN-2-YLIDENE) HETNAM 2 KPI AMINO]HEXANOIC ACID FORMUL 1 KPI 2(C9 H16 N2 O4) FORMUL 3 HOH *388(H2 O) HELIX 1 1 GLY A 13 GLY A 18 1 6 HELIX 2 2 ASP A 35 LYS A 49 1 15 HELIX 3 3 THR A 67 GLY A 83 1 17 HELIX 4 4 ASN A 96 ALA A 110 1 15 HELIX 5 5 SER A 126 THR A 141 1 16 HELIX 6 6 ILE A 150 GLY A 155 1 6 HELIX 7 7 GLU A 159 SER A 167 1 9 HELIX 8 8 ASP A 181 GLY A 193 1 13 HELIX 9 9 ASP A 200 PRO A 202 5 3 HELIX 10 10 LEU A 203 LEU A 210 1 8 HELIX 11 11 VAL A 218 ALA A 222 5 5 HELIX 12 12 ALA A 223 GLY A 237 1 15 HELIX 13 13 ASP A 238 LEU A 249 1 12 HELIX 14 14 LEU A 249 GLY A 260 1 12 HELIX 15 15 GLY A 260 GLN A 272 1 13 HELIX 16 16 ASN A 287 ALA A 301 1 15 HELIX 17 17 GLY B 13 GLY B 18 1 6 HELIX 18 18 ASP B 35 LYS B 49 1 15 HELIX 19 19 THR B 67 GLY B 83 1 17 HELIX 20 20 ASN B 96 ALA B 110 1 15 HELIX 21 21 SER B 126 THR B 141 1 16 HELIX 22 22 ILE B 150 GLY B 155 1 6 HELIX 23 23 GLU B 159 SER B 167 1 9 HELIX 24 24 ASP B 181 GLY B 193 1 13 HELIX 25 25 ASP B 200 PRO B 202 5 3 HELIX 26 26 LEU B 203 LEU B 210 1 8 HELIX 27 27 VAL B 218 ALA B 222 5 5 HELIX 28 28 ALA B 223 GLU B 236 1 14 HELIX 29 29 ASP B 238 LEU B 249 1 12 HELIX 30 30 LEU B 249 GLY B 260 1 12 HELIX 31 31 GLY B 260 GLN B 272 1 13 HELIX 32 32 ASN B 287 ALA B 301 1 15 SHEET 1 A 9 VAL A 20 ALA A 23 0 SHEET 2 A 9 SER A 53 LEU A 56 1 O VAL A 55 N VAL A 22 SHEET 3 A 9 LYS A 87 GLY A 91 1 O ILE A 89 N LEU A 54 SHEET 4 A 9 GLY A 114 VAL A 118 1 O LEU A 116 N ALA A 90 SHEET 5 A 9 ILE A 145 ASP A 149 1 O CYS A 146 N LEU A 115 SHEET 6 A 9 ILE A 172 ASP A 177 1 O KPI A 176 N LEU A 147 SHEET 7 A 9 ALA A 195 SER A 198 1 O TYR A 197 N ASP A 177 SHEET 8 A 9 GLY A 214 SER A 217 1 O GLY A 214 N SER A 198 SHEET 9 A 9 VAL A 20 ALA A 23 1 N GLY A 21 O SER A 217 SHEET 1 B 9 VAL B 20 ALA B 23 0 SHEET 2 B 9 SER B 53 LEU B 56 1 O VAL B 55 N VAL B 22 SHEET 3 B 9 LYS B 87 GLY B 91 1 O ILE B 89 N LEU B 54 SHEET 4 B 9 GLY B 114 VAL B 118 1 O LEU B 116 N ALA B 90 SHEET 5 B 9 ILE B 145 ASP B 149 1 O CYS B 146 N LEU B 115 SHEET 6 B 9 ILE B 172 ASP B 177 1 O KPI B 176 N LEU B 147 SHEET 7 B 9 ALA B 195 SER B 198 1 O TYR B 197 N ASP B 177 SHEET 8 B 9 GLY B 214 SER B 217 1 O GLY B 214 N SER B 198 SHEET 9 B 9 VAL B 20 ALA B 23 1 N GLY B 21 O SER B 217 LINK C VAL A 175 N KPI A 176 1555 1555 1.35 LINK C KPI A 176 N ASP A 177 1555 1555 1.34 LINK C VAL B 175 N KPI B 176 1555 1555 1.35 LINK C KPI B 176 N ASP B 177 1555 1555 1.34 CISPEP 1 LEU A 281 PRO A 282 0 1.28 CISPEP 2 LEU B 281 PRO B 282 0 1.06 CRYST1 135.300 54.810 98.610 90.00 129.39 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007391 0.000000 0.006069 0.00000 SCALE2 0.000000 0.018245 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013122 0.00000